HomeCompareOTIIX vs JNJ

OTIIX vs JNJ: Dividend Comparison 2026

OTIIX yields 7.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OTIIX wins by $11.8K in total portfolio value
10 years
OTIIX
OTIIX
● Live price
7.00%
Share price
$57.94
Annual div
$4.06
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.8K
Annual income
$1,092.45
Full OTIIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OTIIX vs JNJ

📍 OTIIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOTIIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OTIIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OTIIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OTIIX
Annual income on $10K today (after 15% tax)
$595.22/yr
After 10yr DRIP, annual income (after tax)
$928.58/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OTIIX beats the other by $224.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OTIIX + JNJ for your $10,000?

OTIIX: 50%JNJ: 50%
100% JNJ50/50100% OTIIX
Portfolio after 10yr
$25.9K
Annual income
$960.12/yr
Blended yield
3.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OTIIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OTIIX buys
0
JNJ buys
0
No recent congressional trades found for OTIIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOTIIXJNJ
Forward yield7.00%3.36%
Annual dividend / share$4.06$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.8K$20.0K
Annual income after 10y$1,092.45$827.78
Total dividends collected$9.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OTIIX vs JNJ ($10,000, DRIP)

YearOTIIX PortfolioOTIIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,400$700.26$10,676$355.77+$724.00OTIIX
2$12,944$746.09$11,407$389.39+$1.5KOTIIX
3$14,642$791.72$12,198$426.53+$2.4KOTIIX
4$16,504$836.98$13,056$467.62+$3.4KOTIIX
5$18,541$881.69$13,987$513.12+$4.6KOTIIX
6$20,765$925.71$14,998$563.56+$5.8KOTIIX
7$23,187$968.91$16,098$619.52+$7.1KOTIIX
8$25,821$1,011.16$17,295$681.69+$8.5KOTIIX
9$28,681$1,052.37$18,599$750.82+$10.1KOTIIX
10$31,781$1,092.45$20,022$827.78+$11.8KOTIIX

OTIIX vs JNJ: Complete Analysis 2026

OTIIXStock

The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in stocks of small companies. The manager defines a small company as one whose market capitalization falls (i) within or below the current range of companies in either the Russell 2000® Index or the S&P SmallCap 600 Index or (ii) below the three-year average maximum market cap of companies in either index as of December 31 of the three preceding years.

Full OTIIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OTIIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OTIIX vs SCHDOTIIX vs JEPIOTIIX vs OOTIIX vs KOOTIIX vs MAINOTIIX vs ABBVOTIIX vs MRKOTIIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.